Total Combined Global Risk Assessment Applied to Pharmaceutical Equivalence – a Case Study of Ofloxacin Medicines
Author:
Caffaro Arthur M.,Lourenco Felipe R.
Reference35 articles.
1. Evaluation of Therapeutic Equivalence -Guidance for Industry;Food and Drug Administration (FDA),2022